US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Report updated on 11th September, 2021: Global Bioactive Coating Devices Market 2021 (Includes Business Impact of COVID-19)Global Bioactive Coating Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global bioactive coating devices market report has been segmented on the basis of product type, application, material, end user, and region Request Covid - 19 Impact The global Bioactive Coating Devices market size was valued at USD $1.23 billion in 2020 and is projected to reach USD $2.74 billion by 2030 is anticipated to expand at a CAGR of 8.33% over the forecast period from 2020 to 2030.
Global Bioactive Coating Devices Market: OverviewBlood clotting creates on obstruction for the implantable device to perform and can also result in devices failure which is a major concern among orthopedic and other doctors. Bioactive compounds allow direct bonding of living tissues and osteoconduction. Continuous research and development activities are being carried out in order for the development of new implantable devices that have a thin film of bioactive molecules or drugs. These devices aid in preventing device failure and inflammation and also enhances the integration of the device with the tissues
Global Bioactive Coating Devices Market: DynamicsIncreasing adoption of various implantable medical devices, such as stents, heart valves, etc. in order to improve patients lives, coupled with rising adoption of bioactive coating in order to control the failure of implantable devices is a major factor expected to drive growth of the global bioactive coating devices market In addition, increasing prevalence of chronic diseases such as systemic joint, cardiovascular diseases, etc. across the globe, rising government spending on development of healthcare infrastructure, and shifting focus on cell biology and reduction of antimicrobial contamination in order to restrict usage of antibiotics are among other factors expected to further boost the market growth. However, high cost of R&D activities and lack of infrastructural facilities are some major factors expected to hamper growth of the global bioactive coating market. In addition, stringent government regulations related to product approval is another factor expected to further challenge the growth of the global market. Increasing investment by major players for technological advancements and R&D activities are expected to create new opportunities in terms of revenue for players operating in the global market over the forecast period. In addition, growing public-private partnership for R&D activities and innovative product offerings is expected to further support growth of the global market to a certain extent.
Global Bioactive Coating Devices Market: SegmentAmong the product type segments, the drug-eluting coating segment is expected to dominate in the target market over the forecast period Among the application segments, the hospital segment is expected to witness moderate growth in the target market over the forecast period
Global Bioactive Coating Devices Market: RegionThe market in North American is expected to dominate the global bioactive coating market and is expected to continue its dominance over the forecast period. This dominance can be attributed to well-developed healthcare infrastructure for R&D activities, increasing adoption of implants, favorable reimbursement policies, and the presence of major players operating in the countries in this region. In addition, growing merger and acquisition activities between regional and international players is expected to further support the market growth in this region. The market in Asia Pacific is expected to witness faster growth, owing to changing regulatory scenario, and the increasing presence of major manufacturers in emerging economies in this region. In addition, increasing government expenditure on the development of healthcare infrastructure is resulting in technological advancements in medical devices by regional players.
Below are the active patents related to Bioactive Coating Devices Market.Patent Number: US20150010715A1 Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation Abstract The present invention provides antimicrobial coatings for coating substrate surfaces, particularly medical devices, for preventing bacterial adhesion and biofilm formation by inhibiting microbial growth and proliferation on the coating surface. The antimicrobial coatings are composed of a hydrogel and a bioactive agent including a substantially water-insoluble antimicrobial metallic material that is solubilized within the coating. Antimicrobial coating formulations for obtaining such coatings, and coating methods are also described. Application filed Date: 2014-05-02 Application granted Date:2017-09-19 Current Assignee: BACTERIN Patent Number: US9789228B2 Antimicrobial coatings for medical devices and processes for preparing such coatings Abstract Antimicrobial formulations and coatings for medical devices and processes therefor are disclosed. The formulations include at least one water permeable polymer with at least one antimicrobial agent in a liquid medium and are prepared by wet milling the components and can form antimicrobial coatings having uniformly dispersed particles having an average size of no greater than 50 microns. Application filed Date: 2014-12-11 Application granted Date: 2017-10-17 Current Assignee: Covidien LP
Global Bioactive Coating Devices Market Segmentation:Segmentation by product type
Table of Contents Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data SourcesChapter 2. Executive SummaryChapter 3. Global Bioactive Coating Devices Market Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects, 2016 - 2027 3.3. Value Chain Analysis 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis | read more...